ALPS Advisors’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $29.4M | Sell |
484,385
-36,441
| -7% | -$2.12M | 0.14% | 79 |
|
|
2025
Q4 | $28.1M | Sell |
520,826
-52,480
| -9% | -$2.52M | 0.16% | 70 |
|
|
2025
Q3 | $25.9M | Buy |
573,306
+100,980
| +21% | +$4.72M | 0.14% | 78 |
|
|
2025
Q2 | $21.9M | Buy |
472,326
+62,914
| +15% | +$3.09M | 0.13% | 107 |
|
|
2025
Q1 | $25M | Sell |
409,412
-24,893
| -6% | -$1.45M | 0.14% | 76 |
|
|
2024
Q4 | $24.6M | Sell |
434,305
-56,153
| -11% | -$3.14M | 0.16% | 73 |
|
|
2024
Q3 | $25.4M | Sell |
490,458
-152,474
| -24% | -$7.15M | 0.17% | 73 |
|
|
2024
Q2 | $26.7M | Buy |
642,932
+114,959
| +22% | +$5.14M | 0.18% | 59 |
|
|
2024
Q1 | $28.6M | Sell |
527,973
-9,218
| -2% | -$470K | 0.2% | 56 |
|
|
2023
Q4 | $27.6M | Buy |
537,191
+430,928
| +406% | +$22.6M | 0.22% | 56 |
|
|
2023
Q3 | $6.17M | Buy |
106,263
+17,825
| +20% | +$1.09M | 0.05% | 175 |
|
|
2023
Q2 | $5.66M | Sell |
88,438
-2,446
| -3% | -$164K | 0.05% | 182 |
|
|
2023
Q1 | $6.3M | Sell |
90,884
-2,656
| -3% | -$187K | 0.06% | 162 |
|
|
2022
Q4 | $6.73M | Sell |
93,540
-359,487
| -79% | -$27.1M | 0.06% | 169 |
|
|
2022
Q3 | $32.2M | Buy |
453,027
+86,213
| +24% | +$6.25M | 0.3% | 47 |
|
|
2022
Q2 | $28.2M | Sell |
366,814
-45,009
| -11% | -$3.43M | 0.27% | 53 |
|
|
2022
Q1 | $30.1M | Sell |
411,823
-62,636
| -13% | -$4.21M | 0.33% | 36 |
|
|
2021
Q4 | $29.6M | Buy |
+474,459
| New | +$27.8M | 0.33% | 38 |
|
|
2020
Q4 | – | Sell |
-310,475
| Closed | -$18.7M | – | 843 |
|
|
2020
Q3 | $18.7M | Sell |
310,475
-41,824
| -12% | -$2.52M | 0.28% | 67 |
|
|
2020
Q2 | $20.7M | Sell |
352,299
-71,832
| -17% | -$4.3M | 0.28% | 57 |
|
|
2020
Q1 | $23.6M | Sell |
424,131
-157,622
| -27% | -$9.63M | 0.37% | 42 |
|
|
2019
Q4 | $37.3M | Sell |
581,753
-154,574
| -21% | -$8.85M | 0.29% | 53 |
|
|
2019
Q3 | $37.3M | Sell |
736,327
-54,859
| -7% | -$2.58M | 0.29% | 46 |
|
|
2019
Q2 | $35.9M | Buy |
791,186
+15,805
| +2% | +$736K | 0.27% | 82 |
|
|
2019
Q1 | $37M | Sell |
775,381
-8,171
| -1% | -$407K | 0.26% | 85 |
|
|
2018
Q4 | $40.7M | Buy |
783,552
+728,580
| +1,325% | +$39.1M | 0.32% | 48 |
|
|
2018
Q3 | $3.41M | Buy |
+54,972
| New | +$3.26M | 0.02% | 192 |
|
|
2018
Q1 | – | Sell |
-8,629
| Closed | -$529K | – | 883 |
|
|
2017
Q4 | $529K | Sell |
8,629
-1,142
| -12% | -$71.4K | ﹤0.01% | 493 |
|
|
2017
Q3 | $623K | Sell |
9,771
-758
| -7% | -$44.3K | ﹤0.01% | 334 |
|
|
2017
Q2 | $587K | Sell |
10,529
-140
| -1% | -$7.62K | ﹤0.01% | 368 |
|
|
2017
Q1 | $580K | Buy |
10,669
+1,021
| +11% | +$56K | ﹤0.01% | 296 |
|
|
2016
Q4 | $564K | Buy |
9,648
+528
| +6% | +$28.9K | ﹤0.01% | 308 |
|
|
2016
Q3 | $492K | Buy |
+9,120
| New | +$586K | ﹤0.01% | 277 |
|
|
2013
Q4 | – | Sell |
-181,215
| Closed | -$8.39M | – | 586 |
|
|
2013
Q3 | $8.39M | Buy |
181,215
+60,589
| +50% | +$2.66M | 0.09% | 59 |
|
|
2013
Q2 | $5.39M | Buy |
+120,626
| New | +$5.24M | 0.07% | 83 |
|
Other funds holding BMY
VCM
VPM
ALPS Advisors's BMY Position: Q1 2026 in Review
ALPS Advisors reduced its Bristol-Myers Squibb (BMY) stake by 7% in Q1 2026, selling an estimated $2.12M and leaving 484,385 shares worth $29.4M. The position accounts for 0.14% of the portfolio, ranked #79.
ALPS Advisors first reported a position in BMY in Q2 2013 and has held it in 35 quarters since. The position peaked at $40.7M in Q4 2018. 2,518 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- ALPS Advisors held 484,385 shares of Bristol-Myers Squibb worth $29.4M as of Q1 2026.
- ALPS Advisors sold 36,441 Bristol-Myers Squibb shares in Q1 2026, an estimated $2.12M.
- Bristol-Myers Squibb made up 0.14% of ALPS Advisors's portfolio in Q1 2026, its #79 holding.
- ALPS Advisors first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 35 quarters since.
- ALPS Advisors's Bristol-Myers Squibb position peaked at $40.7M in Q4 2018.
- 2,518 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on ALPS Advisors's 13F filing for Q1 2026, filed 8 May 2026.